Human FcR Blocking Reagent Others and produced by rheumatoid arthritis

and produced by rheumatoid arthritis synovium

GOLM2 Accession Q8NBJ4 Amino Acid Sequence Protein sequence(Q8NBJ4

mediating bi-directional signaling during tumorogenesis and various developmental events

Cationic antimicrobial protein CAP37 Immunogen Recombinant Protein Accession P20160 Clone Number SDT-506-97 Antibody Type Recombinant mAb Isotype IgG Application Lateral Flow

Human FcR Blocking Reagent Others and produced by rheumatoid arthritisProduct Specification Host Human Application Fc receptor blocking Reactivity Hu Purification Protein G Concentration 5 mg ml Conjugation Unconjugated Physical Appearance Liquid Storage Buffer PBS pH7. 4, 0. 03% Proclin 300 Stability & Storage 12 months from date of receipt reconstitution, 2 to 8 C as supplied Dilution application dilution species FCM 20l per 10^7 cells in 1ml volume Hu Background FcR Blocking Reagent is a specialized reagent used in